Physician profile
Mark Barinque
NPI 1427118520
$10,923.19
in general payments reported to CMS, 2019-2025
14 companies · $6,876 in 2025
The $6,876 reported for 2025 was more than what 97% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $1,117 · 2021: $1,558 · 2022: $86.67 · 2023: $171 · 2024: $640 · 2025: $6,876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,132 · Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,132.48 |
| Food and Beverage | $555.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $9,030.92 | 2020-2025 | |
| Paragon 28, INC. | $570.37 | 2024 | Portfolio, Plating Portfolio |
| Tactile Systems Technology INC | $504.73 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Sandoz INC. | $204.85 | 2019-2020 | |
| Next Science LLC | $121.90 | 2023 | Xperience, Blastx, Surgx |
| Smith+Nephew, INC. | $77.97 | 2021-2023 | Stravix |
| Organogenesis INC. | $75.89 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $67.07 | 2025 | Nuzyra |
| Nabriva Therapeutics, Plc | $66.36 | 2021 | |
| Orthofix Medical, INC. | $44.45 | 2024-2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.30 | 2020-2022 | |
| Medline Industries Lp | $42.69 | 2019 | |
| Merck Sharp & Dohme LLC | $39.32 | 2019 | |
| Dynasplint Systems INC. | $33.37 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Barinque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.